Cargando…

Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases

Fibrosis is a common healing process that occurs during stress and injury in cardiovascular diseases. The evolution of fibrosis is associated with cardiovascular disease states and causes adverse effects. Fibroblast activation is responsible for the formation and progression of fibrosis. The incipie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yan, Wang, Yuxiang, Wang, Shu, Du, Bulin, Li, Xuena, Li, Yaming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531835/ https://www.ncbi.nlm.nih.gov/pubmed/37762974 http://dx.doi.org/10.3390/jcm12186033

Ejemplares similares

Can (18)F-FDG PET/CT predict EGFR status in patients with non-small cell lung cancer? A systematic review and meta-analysis
por: Du, Bulin, et al.
Publicado: (2021)

PD-L1 in Lung Adenocarcinoma: Insights into the Role of (18)F-FDG PET/CT
por: Cui, Yan, et al.
Publicado: (2020)

FAPI PET/CT in Diagnostic and Treatment Management of Colorectal Cancer: Review of Current Research Status
por: Cheng, Zhiming, et al.
Publicado: (2023)

Discordant Metabolic Response on (18)F-FDG PET/CT in Synchronous Primary Gastric Lymphoma and Gastric Adenocarcinoma
por: Hao, Wanting, et al.
Publicado: (2022)

Positron emission tomography/computed tomography hypermetabolism of Kikuchi–Fujimoto disease mimicking malignant lymphoma: a case report and literature review
por: Wang, Shu, et al.
Publicado: (2021)

A Renal Cyst Invaded by Infiltrating Renal Cell Carcinoma With Multiple Hypermetabolic Bone Metastases as the Initial Presentation
por: Wang, Shu, et al.
Publicado: (2022)

Fuzzy Planar Cell Polarity Gene (FUZ) Promtes Cell Glycolysis, Migration, and Invasion in Non-small Cell Lung Cancer via the Phosphoinositide 3-Kinase/Protein Kinase B Pathway
por: Wang, Shu, et al.
Publicado: (2022)

The long noncoding RNA HOXA11‐AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA‐148b‐3p/PKM2 axis
por: Chen, Wenkun, et al.
Publicado: (2022)

The Synthesis and Evaluations of the (68)Ga-Lissamine Rhodamine B (LRB) as a New Radiotracer for Imaging Tumors by Positron Emission Tomography
por: Li, Xuena, et al.
Publicado: (2016)

MicroRNA-4458 suppresses migration and epithelial–mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells
por: Ma, Yu, et al.
Publicado: (2019)

Effect of IDH3a on glucose uptake in lung adenocarcinoma: A pilot study based on [(18)F]FDG
por: Du, Bulin, et al.
Publicado: (2019)

Targeted inhibition of glutamine metabolism enhances the antitumor effect of selumetinib in KRAS-mutant NSCLC
por: Xia, Meng, et al.
Publicado: (2020)

Radiolabeled fibroblast activation protein inhibitors in the evaluation of myocardial fibrosis
por: Su, Xiangyu, et al.
Publicado: (2023)

PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway
por: Wang, Shu, et al.
Publicado: (2023)

Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management
por: Kuyumcu, Serkan, et al.
Publicado: (2021)

Thyroid Remnant Estimation by Diagnostic Dose (131) I Scintigraphy or (99m) T c O (4) (−) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131) I Imaging
por: Liu, Guanghui, et al.
Publicado: (2016)

ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway
por: Sun, Tong, et al.
Publicado: (2019)

LncRNA AP000695.2 promotes glycolysis of lung adenocarcinoma via the miR-335-3p/TEAD1 axis: The role of AP000695.2 in glycolysis of lung adenocarcinoma
por: Xu, Shuoyan, et al.
Publicado: (2023)

TRAF6 Suppresses the Development of Pulmonary Fibrosis by Attenuating the Activation of Fibroblasts
por: Min, Jiali, et al.
Publicado: (2022)

Roles of Exosomes in Cardiac Fibroblast Activation and Fibrosis
por: Hohn, Julia, et al.
Publicado: (2021)

Roles of Epigenetics in Cardiac Fibroblast Activation and Fibrosis
por: Shao, Jingrong, et al.
Publicado: (2022)

The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies
por: Dong, Yanzhao, et al.
Publicado: (2023)

Extracellular vesicle‐packaged ILK from mesothelial cells promotes fibroblast activation in peritoneal fibrosis
por: Huang, Qiang, et al.
Publicado: (2023)

Cardiac fibroblast activation in Fabry disease on (18)F-fibroblast activation protein inhibitor positron emission tomography/computed tomography imaging
por: Wang, Yi-Lu, et al.
Publicado: (2022)

Epigenetics in Cardiac Fibrosis: Emphasis on Inflammation and Fibroblast Activation
por: Felisbino, Marina B., et al.
Publicado: (2018)

Mesoporous Polydopamine Loaded Pirfenidone Target to Fibroblast Activation Protein for Pulmonary Fibrosis Therapy
por: Fang, Qi, et al.
Publicado: (2022)

Cardiac Fibrosis and Fibroblasts
por: Kurose, Hitoshi
Publicado: (2021)

S100A4(+) Macrophages Are Necessary for Pulmonary Fibrosis by Activating Lung Fibroblasts
por: Li, Yanan, et al.
Publicado: (2018)

Oxidatively stressed extracellular microenvironment drives fibroblast activation and kidney fibrosis
por: Li, Li, et al.
Publicado: (2023)

PET imaging to assess fibroblast activation protein inhibitor biodistribution: A training program adapted to pharmacology education
por: Ge, Luna, et al.
Publicado: (2022)

BMPER Ameliorates Renal Fibrosis by Inhibiting Tubular Dedifferentiation and Fibroblast Activation
por: Xie, Ting, et al.
Publicado: (2021)

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
por: Syed, M., et al.
Publicado: (2020)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2013)

GRK5 is a regulator of fibroblast activation and cardiac fibrosis
por: Eguchi, Akito, et al.
Publicado: (2021)

Fibroblast Growth Factor Inhibitors in Lung Fibrosis: Friends or Foes?
por: Guzy, Robert
Publicado: (2020)

TRIB3 Mediates Fibroblast Activation and Fibrosis though Interaction with ATF4 in IPF
por: Wang, Lan, et al.
Publicado: (2022)

Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis
por: Yang, Ai-Ting, et al.
Publicado: (2022)

Pharmacological Inhibition of S100A4 Attenuates Fibroblast Activation and Renal Fibrosis
por: Wen, Jia, et al.
Publicado: (2022)

Isolation of Fibroblast-Activation Protein-Specific Cancer-Associated Fibroblasts
por: Huang, Yingying, et al.
Publicado: (2017)

Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation
por: Chen, Xiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7bppre5nf3fdr6pgqst1uh872b